BioCentury
ARTICLE | Clinical News

ENMD-2076 regulatory update

July 28, 2014 7:00 AM UTC

CASI (formerly EntreMed Inc.) said FDA granted Orphan Drug designation to ENMD-2076 to treat hepatocellular carcinoma (HCC). The inhibitor of aurora kinase A ( AURKA; Aurora-A) and multiple tyrosin...